Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-HTP and L-DOPA in Spinal Cord Injury
NCT04000919Phase 3Suspended
- Start
- Jun 2019
- Primary completion
- Jun 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of 5-hydroxytryptophan and levodopa in spinal cord injury (SCI). Started Jun 2019; status: suspended.
02
Drugs
5-hydroxytryptophanlevodopa
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT04000919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04000919.